Home
News
Create
Screeners
Insights
Auro Laboratories
291.
10
-7.05
(-2.36%)
Market Cap
₹181.41 Cr
PE Ratio
101.07
Industry
Healthcare
Buy
Sell
Company Performance:
1D
-2.36%
1M
+29.26%
6M
+16.46%
1Y
+37.08%
5Y
+219.01%
View Company Insights
Latest news about Auro Laboratories
Auro Laboratories Reports Strong Q3FY26 Results with 206% Revenue Growth
Feb 05, 2026
Auro Laboratories Limited reported exceptional Q3FY26 results with revenue from operations surging 206% to ₹939.30 lakhs and net profit jumping to ₹195.18 lakhs from ₹5.10 lakhs in Q3FY25. The nine-month performance also remained strong with revenue growing 76% to ₹2,090.56 lakhs and net profit increasing 129% to ₹266.18 lakhs. The Board approved these results on February 5, 2026, following audit committee review and statutory auditor's limited review.
Auro Laboratories Limited Schedules Board Meeting on February 05, 2026 for Q3FY26 Financial Results
Jan 28, 2026
Auro Laboratories Secures WHO-GMP Certification for API Manufacturing Facility
Nov 13, 2025
Auro Laboratories Reports Quarterly Loss of Rs 71.58 Lakhs
Nov 13, 2025
Auro Laboratories Announces Key Management Changes and Auditor Appointments
Aug 23, 2025
Get More Market Insights with
Heatmap
FII/DII
Company Filings
MF Holdings
Bulk/Block Deals
Stock Rental via SLBM
Signals
MTF Insights
F&O Ban - MWPL
Top Deliveries
Market Valuation